Login / Signup
Chayodom Maneechote
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 4
Top Topics
Atrial Fibrillation
Systematic Review
Endoplasmic Reticulum
Squamous Cell
Top Venues
Pharmaceutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Chayodom Maneechote
,
Siripron C Chattipakorn
,
Siriporn C Chattipakorn
Recent Advances in Mitochondrial Fission/Fusion-Targeted Therapy in Doxorubicin-Induced Cardiotoxicity.
Pharmaceutics
15 (4) (2023)
Chayodom Maneechote
,
Siripron C Chattipakorn
,
Siriporn C Chattipakorn
Recent Advances in Mitochondrial Fission/Fusion-Targeted Therapy in Doxorubicin-Induced Cardiotoxicity.
Pharmaceutics
15 (4) (2023)
Chayodom Maneechote
,
Siripron C Chattipakorn
,
Siriporn C Chattipakorn
Recent Advances in Mitochondrial Fission/Fusion-Targeted Therapy in Doxorubicin-Induced Cardiotoxicity.
Pharmaceutics
15 (4) (2023)
Chayodom Maneechote
,
Siripron C Chattipakorn
,
Siriporn C Chattipakorn
Recent Advances in Mitochondrial Fission/Fusion-Targeted Therapy in Doxorubicin-Induced Cardiotoxicity.
Pharmaceutics
15 (4) (2023)